Delivery Order SPE2DX22D0010-SPE2D824FKH00
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $5,885.39 firm fixed-price delivery order is for NUCYNTA TABS 50MG, a pain management medication. The contract has an ultimate completion date of January 16, 2024 and does not have a set-aside designation, indicating full and open competition. Amerisourcebergen, as a major pharmaceutical distributor, holds a significant...
- This federal contract award to Amerisourcebergen Drug Corp is a $1,837.56 firm fixed-price delivery order from the Defense Logistics Agency (DLA), a defense agency. The contract is not set aside and provides for the delivery of NUCYNTA 50 MG TABLET 100S, a pharmaceutical product, with a period of performance through June 13, 2025. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a significant $999,999,999.00 Indefinite Delivery Contract...
- This federal contract award, valued at $3,331.86, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which does not have a set-aside designation, is for the delivery of NUCYNTA TABS 50MG, a pharmaceutical product. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- This federal contract award, valued at $1,225.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order awarded under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract covers the delivery of NUCYNTA 50 MG TABLET 100S, a pharmaceutical product, to support military...
- This federal contract award, valued at $5,512.79, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, which does not have a set-aside designation, is a delivery order contract for the supply of NUCYNTA TABS 50MG, a pharmaceutical product. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
- This federal contract award, with a value of $4,260.41, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of NUCYNTA TABS 75MG, a prescription pharmaceutical product, with a period of performance through June 26, 2024. Amerisourcebergen Drug Corp, a subsidiary of the large pharmaceutical distribution company Amerisourcebergen Corporation, holds a significant Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,002.77 firm fixed-price delivery order is for the supply of 100 tablets of the medication NUCYNTA 50 MG. The award has an ultimate completion date of May 23, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a $5,592.00 firm fixed-price delivery order for the supply of 4565132195 NUCYNTA 100 MG TABLET 100S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. Amerisourcebergen, one of the largest pharmaceutical distribution companies, has a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $1,722.54 firm fixed-price contract is for the supply of 100 mg NUCYNTA tablets, with a completion date of May 1, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is a Delivery Order valued at $2,516.38 with a period of performance through March 14, 2025. The award was made by the Defense Logistics Agency (DLA), a defense agency, for the supply of NUCYNTA 50 MG TABLET 100S, a pharmaceutical product. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D824FKH00Delivery Order
This federal contract award SPE2DX22D0010|SPE2D824FKH00, with a ceiling value of $5,066.50, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of NUCYNTA TABS 100MG, a pharmaceutical product, with a period of performance through March 1, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.1k | 2/29/24 |